We recommend using a newer internet browser, such as Google Chrome or Microsoft Edge, to optimize your browsing experience.

Skip to main content

Assess the Efficacy and Safety of BDP HFA Nasal Aerosol in Patients 12 Years and Older

- Seasonal Female, Maleergic Rhinitis | Hayfever
- Completed

Study Title: Study to Assess the Efficacy and Safety of BDP HFA Nasal Aerosol in Patients 12 Years and Older With SAR

Teva Identifier: BDP-AR-201

ClinicalTrials.gov Identifier: NCT00854360

Study Status: Completed

Trial Condition(s): Seasonal Female, Maleergic Rhinitis | Hayfever

Interventions: Drug: Beclomethasone dipropionate HFA Nasal Aerosol | Drug: Placebo

Study Description: Please refer to ClinicalTrials.gov for a description of the trial

ClinicalTrials.gov study records with inclusion and exclusion criteria

Key Participation Requirements

Gender: Female, Male

Age Range: 12 Years and older

Trial Duration: 03/01/2009 - 05/01/2009

Phase: Phase 2

Study Type

Interventional